Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AstraZeneca PLC (GB:AZN)
LSE:AZN
AstraZeneca (AZN) Share Price & Analysis
288 Followers
AZN Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range9,314.90p - 12,079.25p
Previous Close11,268p
Volume248.10K
Average Volume (3M)2.87M
Market Cap
£174.68B
Enterprise Value192.98B
Total Cash (Recent Filing)$5.84B
Total Debt (Recent Filing)$28.62B
Price to Earnings (P/E)36.4
Beta0.86
Next Earnings
Jul 25, 2024EPS Estimate
£1.62Last Dividend Ex-Date
Feb 22, 2024Dividend Yield2.02%
Share Statistics
EPS (TTM)3.10
Shares Outstanding1,550,189,338
10 Day Avg. Volume2,944,327
30 Day Avg. Volume2,873,868
Standard Deviation0.06
R-Squared0.09
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-11.70
Price to Sales (P/S)486.49
Price to Cash Flow (P/CF)20.20
P/FCF Ratio25.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.35
Enterprise Value/Gross Profit5.14
Enterprise Value/Ebitda21.24
Forecast
1Y Price Target
11,933.44pPrice Target Upside-0.70% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering19
AstraZeneca News
PremiumCompany Announcements
AstraZeneca Sees Strong Growth in Q1 2024
Bulls Say, Bears Say
Bulls Say
Financial PerformanceStrong performance in product sales and alliance revenue, notably with Farxiga, Symbicort, and key oncology drivers.
Investor RelationsThe upcoming May investor day could serve as a catalyst for the company with a potential new mid-term guide expected to exceed consensus.
Pipeline DevelopmentPipeline advancements with several new Phase III starts and potential game-changing clinical trial reads.
Bears Say
DividendThe dividend is flat - another disappointment after a flat decade and two years of minor nudges.
EarningsConcerns regarding mid-term margin and recent quarterly earnings misses are central to the bear case.
GuidanceThe only disappointment is the lack of the guidance upgrade given current implied guidance is below consensus.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.18% Insiders
14.38% Mutual Funds
8.02% Other Institutional Investors
77.42% Public Companies and
Individual Investors
AZN FAQ
What was AstraZeneca PLC’s price range in the past 12 months?
AstraZeneca PLC lowest share price was 9314.90p and its highest was 12079.25p in the past 12 months.
What is AstraZeneca PLC’s market cap?
Currently, no data Available
When is AstraZeneca PLC’s upcoming earnings report date?
AstraZeneca PLC’s upcoming earnings report date is Jul 25, 2024 which is in 89 days.
How were AstraZeneca PLC’s earnings last quarter?
AstraZeneca PLC released its earnings results on Apr 25, 2024. The company reported 1.653p earnings per share for the quarter, beating the consensus estimate of 1.533p by 0.12p.
Is AstraZeneca PLC overvalued?
According to Wall Street analysts AstraZeneca PLC’s price is currently Overvalued.
Does AstraZeneca PLC pay dividends?
AstraZeneca PLC pays a Annually dividend of 156p which represents an annual dividend yield of 2.02%. See more information on AstraZeneca PLC dividends here
What is AstraZeneca PLC’s EPS estimate?
AstraZeneca PLC’s EPS estimate is £1.62.
How many shares outstanding does AstraZeneca PLC have?
AstraZeneca PLC has 1,550,231,100 shares outstanding.
What happened to AstraZeneca PLC’s price movement after its last earnings report?
AstraZeneca PLC reported an EPS of 1.653p in its last earnings report, beating expectations of 1.533p. Following the earnings report the stock price went up 5.937%.
Which hedge fund is a major shareholder of AstraZeneca PLC?
Currently, no hedge funds are holding shares in GB:AZN
---
AstraZeneca Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
11,933.44p (-0.70% Downside)
11,933.44p (-0.70% Downside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
17.17%
Trailing 12-Months
Asset Growth
3.55%
Trailing 12-Months
Company Description
AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
---
AZN Stock 12 Months Forecast
Average Price Target
11,933.44p
▼(-0.70% Downside)
Technical Analysis
Best Analysts Covering AZN
1 Year
1 Year Success Rate
28/34 ratings generated profit
1 Year Average Return
+12.40%
reiterated a buy rating yesterday
Copying Emily Field's trades and holding each position for 1 Year would result in 82.35% of your transactions generating a profit, with an average return of +12.40% per trade.
---